Such GSK3-promoted conditions are observed in IBM tissues, where low IL-10 expression and enhanced IL-1, IL-6 and IFNγ drive the generation of a pro-inflammatory environment containing inflammatory macrophages and CD8+ CTLs that promote tissue damage. The gene discussed is CD8A; the disease is inclusion body myositis.